Table 2.

Antioxidant capacity of the different treatment groups.

Group	ABTS
A	48.17 ± 1.07
B	41.69 ± 3.26
C	44.02 ± 1.94
D	51.12 ± 0.73*
E	50.51 ± 0.90*

Results of analysis of five replicates expressed as mean ± standard error of mean, using one-way ANOVA and Tukey’s post-hoc tests. *p < 0.05 related to group B (single reperfusion).

ABTS, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonate; ANOVA, analysis of variance.